Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $48.91 USD
Change Today -0.08 / -0.16%
Volume 236.1K
PTLA On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William Lis

Chief Executive Officer, President and Director, Portola Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 1 different industries.

See Board Relationships
51$3,352,562
As of Fiscal Year 2014

Background*

Mr. William Lis, also known as Bill, has been the Chief Executive Officer and President of Portola Pharmaceuticals, Inc. since April 2010. Mr. Lis served as Chief Operating Officer of Portola Pharmaceuticals Inc. He served as Vice President of Business and Commercial Development at Portola Pharmaceuticals, Inc. since June 2008. He has over 17 years of experience in biopharmaceutical and medical device sales & marketing, medical affairs, and business development. From ...

Read Full Background

Corporate Headquarters*

270 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-246-7000
Fax: 650-246-7376

Board Members Memberships*

2010-Present
Chief Executive Officer, President and Director

Education*

BS
University of Maryland

Other Affiliations*

Annual Compensation*

Salary$450,000
Total Annual Compensation$450,000

Stock Options*

All Other Compensation$2,000
Exercised Options150,000
Exercised Options Value$3,092,053
Exercisable Options718,292
Exercisable Options Value$13,902,742
Unexercisable Options100,209
Unexercisable Options Value$324,677
Total Value of Options$17,319,472
Total Number of Options968,501

Total Compensation*

Total Annual Cash Compensation$719,750
Total Short Term Compensation$450,000
Other Long Term Compensation$2,000
Total Calculated Compensation$3,352,562
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PTLA:US $48.91 USD -0.08

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PORTOLA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.